Indication
Epclusa is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients 3 years of age and older (see sections 4.2, 4.4 and 5.1).
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Epclusa 150 MG/37,5 MG Granulado Recubierto en SobreSpain · 150 mg + 37,5 mgMarketed
- Epclusa 200 MG/50 MG Granulado Recubierto en SobreSpain · 200 mg + 50 mgMarketed
- Epclusa 400 MG/100 MG Comprimidos Recubiertos con PeliculaSpain · 400 mg + 100 mgMarketed
- Epclusa 150 mg/37,5 mg, omhuld granulaat in sachetNetherlandsAuthorised
- Epclusa 200 mg/50 mg filmomhulde tablet